Skip to main content

“Cerebrovascular Reserve in Moyamoya Disease: Relation to Cerebral Blood Flow, Capillary Dysfunction, Oxygenation, and Energy Metabolism."

New scientific report from Uppsala

📢 Exciting New Study! Gaining Deeper Insights into Moyamoya Disease with Cercare Medical's Neurosuite (CMN)!

🔍 Scientific Report

The study investigated the association of cerebrovascular reserve (CVR) with various cerebral hemodynamic and energy metabolic parameters in Moyamoya disease (MMD), using perfusion imaging (contrast-based MR and arterial spin label magnetic resonance imaging (ASL-MRI) before and after acetazolamide administration.

  • The progressive nature of MMD warrants monitoring of the patient’s cerebral hemodynamics to evaluate treatment efficacy and the possible need for surgical intervention
  • However, the cerebral hemodynamics in MMD is intricate and involves interactions between macrovascular and microvascular blood flow, oxygenation, and energy metabolism.
  • Cerebrovascular Reserve (CVR) and CBF: Homeostasis is initially preserved via autoregulation but over time the ability to avoid ischemia via vessel dilation when cerebral blood flow (CBF) decreases in both the anterior cerebral artery (ACA) and middle cerebral artery (MCA) territories is lost. A CVR test using ASL can be used to evaluate the integrity of this mechanism.
  • Capillary Dysfunction: Lower CVR in the ACA territory is linked to elevated capillary transit time heterogeneity (CTH), indicating microvascular dysfunction and inefficient oxygen delivery.
  • Oxygenation and Energy Metabolism: Decreased CVR in the ACA territory is strongly associated with higher oxygen extraction fraction (OEFmax), suggesting increased oxygen extraction to compensate for lower CBF.
  • CMRO2 and CBF in MCA Territory: Lower CVR in the MCA territory is associated with lower CBF and higher cerebral metabolic rate of oxygen (CMRO2), indicating increased energy consumption in response to ischemic insults.

🌟 The Game-Changer: Cercare Medical Neurosuite

Gain deeper insights into the patient's cerebral hemodynamics and energy metabolism, with the power of Cercare Medical's cutting-edge software. This groundbreaking tool allowed us to non-invasively assess capillary transit time heterogeneity (CTH), oxygen extraction fraction (OEFmax), and cerebral metabolic rate of oxygen (CMRO2max).

🔬 Key Findings:

Analysis revealed a reduced cerebrovascular reserve (CVR) in both anterior cerebral artery (ACA) and middle cerebral artery (MCA) territories. Additionally, we observed lower baseline CBF, elevated CTH, and increased OEFmax in the ACA territory, and lower CVR in the MCA territory was associated with reduced CBF and higher CMRO2max.

💡 Implications for MMD Research:

This report uncovers crucial connections between macrovascular and microvascular blood flow, oxygenation, and energy metabolism in MMD patients. Cercare Medical’s sophisticated analysis provides valuable insights for non-invasive and non-radioactive evaluation and monitoring, potentially guiding surgical decisions and treatment strategies.

🏥 Advancing Patient Care:

Findings highlight the potential of CMN in transforming cerebrovascular research and improving patient outcomes while limiting the need for radioactive PET.. By harnessing the power of advanced imaging technology, we aim to make a significant impact on the diagnosis and management of patients with MMD.

🔍 Learn More About Neurosuite:

Curious about how Cercare Medical Neurosuite can elevate your research?

Meet our team to explore the cutting-edge capabilities of this game-changing software.

#Neuroscience #CerebrovascularResearch #MoyamoyaDisease #CercareMedical #Neurosuite #ResearchBreakthrough #ScienceMatters

We invite you to engage with this research and share your thoughts. Let's collaborate to drive advancements in the understanding and treatment of Moyamoya disease!